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Objectives: Knee osteoarthritis (OA) pain is suggested to be associated with inﬂammation and detri-
mental mechanical loading across the joint. In this cross-sectional study, we simultaneously examined
the inﬂammation and alignment of the lower limb and examined how the pain components varied
depending on the disease progression.
Design: One-hundred sixty female medial type of early- [n ¼ 74 in KellgreneLawrence (K/L) 2] to
advanced-stage (n ¼ 96 in K/L >2) knee OA subjects (70.5 years on average) were enrolled. Knee painwas
evaluated using a pain visual analog scale (VAS) and the pain-related subcategory of the Japanese Knee
Osteoarthritis Measure (JKOM-pain). The serum interleukin (sIL)-6 level reﬂecting synovitis, and the high
sensitivity C-reactive protein (hs-CRP) level were measured to evaluate the severity of inﬂammation. The
anatomical axis angle (AAA) was measured as an alignment index. The b-coefﬁcient was estimated after
adjusting for age and the body mass index (BMI) using a multiple linear regression analysis.
Results:Multiple linear regression analyses showed that the sIL-6 levels, but not AAA, associated with the
pain VAS [b ¼ 10.77 (95% conﬁdence interval (CI): 4.14e17.40), P < 0.01] and JKOM-pain scores [b ¼ 3.19
(95% CI: 1.93e4.44), P < 0.001] in the early stage. Conversely, AAA, but not the sIL-6 levels, was found to
be associated with the pain VAS [b ¼ 1.29 (95% CI: 2.51 to 0.08), P < 0.05] and JKOM-pain scores
[b ¼ 0.49 (95% CI: 0.82 to 0.16), P < 0.01] in the advanced stage.
Conclusions: The presence of a higher level of sIL-6 and the varus alignment of the joint is associated with
pain in early- and advanced-stage knee OA patients, respectively.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Pain is the most prominent and disabling symptom of osteoar-
thritis (OA). Symptom-modifying therapy is the only available
treatment for knee OA; therefore, it is important to understand the: M. Ishijima, Department of
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s Research Society International. Pfactors causing the pain in order to optimally treat this common
disease. The pain in knee OA is a type of nociceptive pain1. It has
been speculated that detrimental mechanical loading across the
joint and inﬂammation, especially synovitis, may be the main fac-
tors associated with the severity of pain1,2.
Detrimental mechanical loading across the knee joint is specu-
lated to be one of the main factors in the pathophysiology of knee
OA. The alignment of the lower limb has been reported to associate
with pain in knee OA3. The malalignment of the lower limb and
excess body mass have both been considered to be risk factors for
the progression of knee OA, due to the association between these
factors and the joint load4e8.
Inﬂammation is also well known to be associated with the
pathophysiology of knee OA. Synovitis in OA may be a secondary
phenomenon related to the cartilage and bone alterations induced
by the release of degenerative compounds from the extracellularublished by Elsevier Ltd. All rights reserved.
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further stimulate cartilage damage. Recently, the role of synovitis in
OA has attracted particular attention, as synovitis has been revealed
to be one of the potential indicators for knee pain and predictive
factors for both structural and symptomatic progression of the
disease10e14.
Interleukin (IL)-6 is a proinﬂammatory cytokine that is pro-
duced in the synovium under conditions of synovitis. The serum
levels of IL-6 in patients with rheumatoid arthritis (RA) were
demonstrated to be related to both the symptoms and progression
of the disease, and the inhibition of IL-6 improved the clinical
outcomes in patients with RA15. IL-6 was also produced by the
synovial membrane in patients with knee OA16, and the serum
levels of IL-6 were associated with the change in knee pain over
5 years17 and with the future prevalence of radiological knee OA18.
The serum levels of high sensitivity C-reactive protein (hs-CRP)
were correlated with inﬂammatory cell inﬁltration in the synovial
membrane and the levels of IL-6 in the synovial ﬂuid19. The hs-CRP
level was also reported to be a predictor of knee pain17. The serum
levels of both IL-6 and hs-CRP were considered to be predictors of a
decreased articular cartilage volume in patients with knee OA19.
Therefore, IL-6, which is associated with synovitis, may also be
involved in the pathogenesis of pain associated with knee OA.
While the detrimental mechanical loading across the joint and
the synovitis are both speculated to be involved in the pain severity
in knee OA, it still remained unclear how the pain components
varied based on the progression of the disease. We hypothesized
that the factors associated with pain in knee OA varied according to
the disease progression. To verify this hypothesis, we divided the
patients into two groups according to the radiographic severity of
knee OA and investigated the pain severity, the serum IL-6 and hs-
CRP levels and the alignment of the lower limb in patients with
knee OA, and examined whether the factors associated with pain in
knee OA varied according to the radiographic disease severity.
Methods
Subjects and methods
This study was approved by the ethics committee of our uni-
versity. Patients who ﬁrst visited the outpatient clinic of Juntendo
Tokyo Koto Geriatric Medical Center to seek therapy for knee pain
due to OA were asked to participate in the study. All patients who
agreed to participate provided their written informed consent
before enrollment in this study. All subjects were postmenopausal
females with medial knee OA who underwent the initial medical
examination at our outpatient clinic between October 2009 and
December 2011. The sample size of this study was determined
based on the number of patients who demonstrated all these
conditions during the study period. The diagnosis of knee OA was
established according to the American College of Rheumatology
criteria20. The inclusion criteria for the present study were (1)
subjects who were able to walk with or without walking aids and
fulﬁlled the criteria for knee OA of the medial femoro-tibial joint,
(2) subjects who were at least 50 years old, but less than 80 years
old, and (3) all subjects had radiographic knee OA with Kellgrene
Lawrence (K/L) grade 2 or more as evaluated by the weight-bearing
antero-posterior X-rays of the tibio-femoral joint using the bilateral
standing extended view21,22. The exclusion criteria included (1)
patients who had received drugs for knee OA [oral (e.g., non-
steroidal anti-inﬂammatory drugs (NSAIDs) and opioid) or intra-
articular injection (e.g., hyaluronic acid and corticosteroids)]
prescribed by physicians in the previous 3 months, (2) those who
had RA or arthritis due to infection or injury, (3) patients who had
undergone joint replacement surgery, (4) patients who hadsecondary knee OA, (5) patients with patello-femoral OAwith a K/L
grade of 3 or higher and (6) patients with severe OA (K/L grade 3 or
higher) in their hip joint.
Radiographic evaluation of the stage of progression and alignment
of the lower extremity
The staging of knee OA on radiographwas assessed using the K/L
grade (scale 1e4)21. All radiographs were taken by experienced
technicians and were quantiﬁed by two readers who were blinded
to the clinical information of the patient (HK and YS). Both intra-
and inter-observer reproducibility rates were good [interclass cor-
relation coefﬁcient (ICC): 0.97 (95% conﬁdence interval (CI): 0.70e
0.97) and 0.95 (95% CI: 0.93e0.98), respectively]. For the statistical
analysis, the patients were divided into two groups according to the
radiographic severity of knee OA, in line with the methodology of
previous reports17,23: including an early-stage group (K/L grade of
2) and an advanced-stage group (K/L grade of 3 and 4) group.
The alignment angle was measured by the method reported
previously24e26. The femoral anatomic axis was found by drawing a
line from the center of the tibial spines to a point 10 cm above the
tibial spines, midway between the medial and lateral femoral sur-
faces. For the tibial anatomic axis, a line was drawn from the center
of the tibial spines to a point 10 cm below the tibial spines, midway
between the medial and lateral tibial surfaces. The internal angles
between the femoral and tibial axes were measured using a com-
puter and the angle was designated as the alignment angle
(anatomical alignment angle e AAA). In this method, AAA under
180 indicates varus knee alignment.
Knee OA pain
Painwas evaluated by a visual analog scale (VAS, 0e100) and the
Japanese Knee Osteoarthritis Measure (JKOM) score27. The JKOM is
a patient-based, self-answered evaluation score that includes four
subcategories: pain and stiffness (JKOM-pain; total of eight ques-
tions, 0e32 points), activities of daily living (ADL) score (total of 10
questions, 0e40 points), participation in social activities score
(total of ﬁve questions, 0e20 points), and general health conditions
(total of two questions, 0e8 points) with 100 points as the
maximum score. The JKOM score is higher in patients with more
pain and physical disability, and this evaluation modality is
considered to have sufﬁcient reliability and validity for studies of
the clinical outcomes of Japanese subjects with knee OA. The
measure has also been shown to have reliability and validity by
means of statistical evaluations and comparison with other health-
related scales, the Western Ontario and McMaster Universities
Arthritis Index (WOMAC) and theMedical Outcomes Study 36-Item
Short-Form Health Survey (SF-36) in our previous study27. We
assessed the pain severity using both the pain VAS score and JKOM-
pain scores in this study.
Serum IL-6 and hs-CRP levels
Serum samples were obtained from all patients on the day that
pain and function were assessed, and radiographs were taken. The
non-fastingmorning blood sampleswere collected from9 to 11 in the
morning at the outpatient clinic. The serum samples were stored
at 80C until they were analyzed. A chemiluminescent enzyme
immunoassay was used for the measurement of the serum IL-6 con-
centration (minimum 0.2 pg/mL; reagent: human IL-6; cartridge and
instrumentation: LumipulseForte; Fujirebio, Tokyo, Japan: intra-assay
and interassay variations less than 5.2% and 6.5%, respectively). The
serum hs-CRP concentration was measured by latex agglutination
nephelometry (reagent: CardioPhase hs-CRP; instrumentation: BN
Table I
Baseline characteristic of the study subjects
Total Early Advanced P
n 160 67 93
Age (years) 70.5 (7.6) 70.2 (6.7) 70.6 (8.2) 0.751
BMI (kg/m2) 24.2 (3.5) 23.2 (3.1) 24.9 (3.5) 0.001*
Pain VAS score
(Min: 0eMax: 100)
52.9 (24.7) 51.0 (26.8) 54.3 (23.1) 0.425
JKOM-pain score
(Min: 0eMax: 32)
14.8 (6.1) 14.1 (5.8) 15.4 (6.4) 0.171
Serum IL-6 (pg/mL) 2.0 (1.0) 2.0 (1.0) 2.1 (0.9) 0.494
Serum hs-CRP (ng/mL) 686.1 (665.8) 629.7 (594.9) 726.8 (712.0) 0.350
AAA (degree) 180.5 (4.1) 182.9 (2.3) 178.8 (4.3) <0.001*
Data are presented as the means and SD. Early: early-stage knee OA (K/L grade 2);
Advanced: advanced-stage knee OA (K/L grade 3 or 4).
* A P values <0.05 were considered to be statistically signiﬁcant.
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and interassay variations less than 2% and 3.5%, respectively).
Statistical analysis
Descriptive statistics of age, body mass index (BMI), IL-6, hs-CRP
and AAA were calculated [mean, standard deviation (SD)]. The in-
dependent t-test was used to compare mean variables between
early and advanced group. To examine the associations between
biomarkers, alignment and knee pain scores, b-coefﬁcient was
estimated after adjusting for age and the BMI using a multiple
linear regression analysis. A P value <0.05 was considered to be
statistically signiﬁcant. All statistical analyses were performed us-
ing the SPSS15.0J software program (SPSS; Chicago, IL, USA).
Results
Baseline characteristics of the patients
A ﬂow chart of the present study is shown in Fig. 1. While 202
patients who underwent the initial medical examination at our
outpatient clinic between October 2009 and December 2011 were
initially enrolled, 22 patients (10.9%) were excluded since they did
not meet the study criteria, the remaining 180 patients were
included in the data analysis. Among these 180 patients, as 20
patients (11.1%) were excluded due to invalid clinical evaluation
scores or incomplete hematological data, so the remaining 160
patients (88.9%) were included in the analysis.
The patient characteristics are shown in Table I. The radio-
graphic OA severities of the patients were 67 (41.9%) with a K/L
grade of 2, 51 (31.9%) with a K/L grade of 3, and 42 (26.2%) with a K/L
grade of 4.While no signiﬁcant differences in the age of the patientsFig. 1. A ﬂow chart of the present study.were observed between the early- (K/L grade 2) and advanced-
stage (K/L grades 3 and 4) knee OA group, the BMI of the patients
with an advanced-stage knee OA was signiﬁcantly higher in com-
parison to that of those with an early-stage knee OA. No signiﬁcant
differences in the pain VAS score, the JKOM-pain score, serum IL-6
and hs-CRP levels were observed between the patients with early-
stage and advanced-stage knee OA. On the other hand, the AAA of
the patients with an advanced-stage knee OA was signiﬁcantly
smaller in comparison to that of the patients with an early-stage
knee OA.
Factors associated with the pain severity in patients with knee OA
A multiple linear regression analysis indicated that the serum
IL-6 levels and the AAA both associated with the pain severity, as
evaluated by the pain VAS score in the patients when whole pa-
tients were included in the analysis (Table II). On the other hand,
the serum levels of IL-6 were solely associated with the pain VAS
score in the patients with early-stage knee OA, while the AAA was
solely associated with the pain VAS score in the patients with
advanced-stage knee OA.
Similarly, when the JKOM-pain score was used to evaluate the
pain severity, the serum IL-6 levels and the AAA were both asso-
ciated with the pain severity in the whole patients (Table III). In
addition, the serum levels of IL-6 and the AAA solely associated
with the JKOM-pain score in the patients with early- and advanced-
stage knee OA respectively, thus conﬁrming that there were dif-
ferences in the pain-associated factors according to the stage of the
disease.
Discussion
The present study has revealed, for the ﬁrst time, that the factors
associated with the pain severity in patients with knee OA varied
with the radiographic disease severity. IL-6, which is related to
synovitis, was mainly associated with the pain severity in early-
stage knee OA, while the AAA was mainly associated with that in
the advanced-stage knee OA.
Synovitis is seen from the early stage of knee OA9,13,14,28,29. The
changes in cartilage matrix turnover detected by several potential
molecular biomarkers were supposed to account directly or indi-
rectly for synovitis and knee pain in patients with an early-stage
knee OA29. More severe chronic synovitis was also seen in the
advanced stage of knee OA than that in the early stage13,30,31. The
severity of chronic synovitis was correlated with the pain severity
and the level of disability in late-stage knee OA patients32. How-
ever, an increased degree of mononuclear cell inﬁltration and
an overproduction of proinﬂammatory cytokines were more
Table II
Factors associating with the pain VAS score in patients with knee OA
Pain VAS score b (95% CI) (crude) P b (95% CI) (adjusted) P
Total IL-6 5.87 (1.57e10.18) <0.01 5.92 (1.48e10.35) <0.01*
hs-CRP 0.002 (0.008e0.004) 0.55 0.002 (0.008e0.005) 0.57
AAA 1.03 (1.95 to 0.12) 0.03 1.04 (2.03 to 0.06) 0.04*
Early IL-6 10.65 (4.16e17.15) <0.01 10.77 (4.14e17.40) <0.01*
hs-CRP 0.000 (0.011e0.012) 0.95 0.002 (0.011e0.015) 0.74
AAA 0.004 (2.683e2.68) 0.99 0.03 (2.74e2.69) 0.99
Advanced IL-6 0.895 (4.87e6.66) 0.76 0.64 (5.44e6.72) 0.86
hs-CRP 0.001 (0.009e0.006) 0.73 0.01 (0.009e0.006) 0.70
AAA 1.36 (2.45 to 0.27) 0.02 1.29 (2.51 to 0.08) 0.04*
A multiple linear regression analysis. Adjusted; adjusted for age and BMI; Early: early-stage knee OA (K/L grade 2); Advanced: advanced-stage knee OA (K/L grade 3 or 4).
* A P values <0.05 were considered to be statistically signiﬁcant.
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stage knee OA28,33. These studies suggest that the proinﬂammatory
cytokinesmay bemainly involved in the synovitis in the early-stage
of knee OA, while synovitis is associated with the pain severity in
early- to advanced-stage in knee OA, as observed in this study
(Tables II and III). The associations between serum levels of IL-6 and
the pain severity in the patients with early-stage knee OA, but not
in those with advanced-stage knee OA, observed in the present
study (Tables II and III), may be related to the results of these
previous studies.
Although the serum hs-CRP, as well as IL-6, levels became high
according to the progression of OA, in patients with early stage, the
levels of IL-6, but not those of hs-CRP, signiﬁcantly associated with
the pain severity. The reason for the difference in this association is
not clear. Circulating IL-6 is known to stimulate CRP production by
the liver. CRP is a component of circulating serum b-globulinwhich
is produced in the liver reacts to systemic and local tissue damage.
IL-6 is a cytokine which is produced at a local site where cellular or
tissue damage occurs. In addition, IL-6 is also produced by adipose
tissue, which accompanies obesity34. As BMI of the patients with
advanced-stage knee OA was signiﬁcantly increased in comparison
to that of those with early-stage knee OA in the present study
(Table I), serum IL-6 levels may be affected by the IL-6 produced by
adipose tissues, in addition to a local site in the knee joint. There-
fore, further study using synovial ﬂuid, which is one of the sources
to observe the local joint event, is necessary to clarify this question.
The mechanical loading across the knee joint, which was esti-
mated by the knee adduction moment (KAM), was speculated to be
higher due to the deteriorating lower limb alignment, and also
because of increasing body weight7. However, it had not been
elucidated to what extent the mechanical loading across the knee
joint contributes to the knee joint pain in patients with knee OA.
There was a weak correlation between the pain severity and either
the radiographic joint space narrowing or the alignment of theTable III
Factors associating with the JKOM-pain score in patients with knee OA
JKOM-pain score b (95% CI) (crude)
Total IL-6 1.75 (0.72e2.78)
hs-CRP 0.000 (0.002e0.001)
AAA 0.40 (0.62 to 0.18)
Early IL-6 3.26 (2.00e4.51)
hs-CRP 0.001 (0.003e0.002)
AAA 0.28 (0.80e0.23)
Advanced IL-6 0.25 (1.31e1.80)
hs-CRP 0.000 (0.002e0.002)
AAA 0.47 (0.76 to 0.17)
A multiple linear regression analysis. Adjusted; adjusted for age and BMI; Early; early-st
* A P values <0.05 were considered to be statistically signiﬁcant.lower limb in patients with early- to advanced-stage knee OA3.
Consistent with this study, the lower limb alignment was weakly
associated with the pain severity in all the patients, with early- and
advanced-stage knee OA in the present study. Moreover, the asso-
ciation between the alignment and the pain severity became clear
in the patients with advanced-stage knee OA, who show a mild to
severe varus alignment of the lower limb, while the associationwas
not signiﬁcant in the patients with early-stage knee OA, who
generally showa normal to less severe varus alignment of the lower
limb (Tables IeIII). In the patients with advanced-stage knee OA, an
association was identiﬁed between pain severity and the KAM,
while no association was observed in the patients with early-stage
knee OA35. Among the early-stage with knee OA (K/L grade 2), the
KAM signiﬁcantly increased in patients with knee pain compared to
those without pain36. Simultaneously, the alignment of lower limb
in the patients with knee pain also signiﬁcantly increased (more
varus lower limb alignment) in comparison to that in thosewithout
knee pain36. Although, it is still remains unclear precisely how joint
loading induces pain in patients with knee OA and such joint
loading was not measured in the present study, the results of the
present study suggest that the pain in the advanced-stage of knee
OA is associated with the mechanical loading across the knee joint,
which is associated with a deterioration of the lower limb
alignment35.
The current study was associated with some limitations. First,
the present study is cross-sectional. The study deals with changes
of the disease pathology according to the progression. Progression
is time-related and ideally, the study should be designed longitu-
dinally. In this context, the results obtained in this study may be
understood as an indirect evidence. Secondly, the patients were
divided into two subgroups for statistical analysis. The number of
patients with advanced-stage OA was more by about 50% than that
with early-stage OA. This may have produced the possibility of
generating statistical bias comparing the two subgroups. Thirdly,P b (95% CI) (adjusted) P
<0.01 1.73 (0.67e2.79) <0.01*
0.68 0.000 (0.002e0.001) 0.70
<0.01 0.40 (0.63 to 0.16) <0.01*
<0.01 3.19 (1.93e4.44) <0.001*
0.65 0.001 (0.004e0.001) 0.24
0.28 0.27 (0.79e0.25) 0.29
0.76 0.34 (1.30e1.97) 0.69
0.82 0.000 (0.002e0.002) 0.76
<0.01 0.49 (0.82 to 0.16) <0.01*
age knee OA (K/L grade 2); Advanced, advanced-stage knee OA (K/L grade 3 or 4).
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rhythm37, the serum sample collection was not timed but collected
in the morning and the patients had not fasted. While it was not
examined whether the serum IL-6 levels show diurnal and activity-
related variations, some biomarkers have been reported to have
such variations38e40. Further studies are required to clarify whether
there are time of day- and activity-related variations in the
expression of IL-6 and hs-CRP38. Because we did not conduct
detailed phenotyping of other joints, the contribution of other
joints to the systemic levels of biomarkers cannot be addressed.
In conclusion, the presence of a higher serum levels of IL-6 is
thus considered to be associated with pain in early-stage knee OA,
while the varus alignment of the joint was found to be associated
with pain in advanced-stage knee OA patients.
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